p16-JC8

Squamous Carcinoma of Cervix stained with Anti-p16

p16-JC8

The progression of cells through the cell cycle is regulated by a family of protein kinases known as cyclin-dependent kinases (Cdks). The sequential activation of individual members of this family and their consequent phosphorylation of critical substrates promotes orderly progression through the cell cycle. The cyclins function as differentially expressed positive regulators of Cdks. Negative regulators of the cycle include the p53-inducible protein p21 (also designated WAF1 or Cip1), Kip1 p27 and p16. The complexes formed by Cdk4 and the D-type cyclins have been strongly implicated in the control of cell proliferation during the G1 phase. It has been shown that p16 binds to Cdk4 and inhibits the catalytic activity of the Cdk4/cyclin D complex. Moreover, the gene encoding p16 exhibits a high frequency of homozygous deletions and point mutations in established human tumor cell lines.

  • Description
  • Specifications
  • Ordering Information

The progression of cells through the cell cycle is regulated by a family of protein kinases known as cyclin-dependent kinases (Cdks). The sequential activation of individual members of this family and their consequent phosphorylation of critical substrates promotes orderly progression through the cell cycle. The cyclins function as differentially expressed positive regulators of Cdks. Negative regulators of the cycle include the p53-inducible protein p21 (also designated WAF1 or Cip1), Kip1 p27 and p16. The complexes formed by Cdk4 and the D-type cyclins have been strongly implicated in the control of cell proliferation during the G1 phase. It has been shown that p16 binds to Cdk4 and inhibits the catalytic activity of the Cdk4/cyclin D complex. Moreover, the gene encoding p16 exhibits a high frequency of homozygous deletions and point mutations in established human tumor cell lines.

  • Source
    Mouse Monoclonal Antibody
  • Clone
    JC8
  • Class
    IVD
  • Isotype
    Mouse, IgG2a
  • Tested Reactivity
    Human, FFPE
  • Localization
    Nucleus & Cytoplasm
  • Positive Control
    Cervical Carcinoma
  • Catalog
    Pack Size
  • PM304-3ml
    3ml (RTU)
  • PM304-6ml
    6ml (RTU)
  • CM304-0.1ml
    0.1ml (Conc.)
  • CM304-0.5ml
    0.5ml (Conc.)
  • HAM304 -3ml
    3ml (RTU)
  • HAM304 -6ml
    6ml (RTU)
  • CM304 - 1ml
    1ml ( Conc. )